首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal BORG3 Antibody

  • 中文名: BORG3抗体
  • 别    名: binder of Rho GTPases 3; Borg3; Cdc42 effector 5; CEP5;
货号: IPDX42339
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

Aliasesbinder of Rho GTPases 3; Borg3; Cdc42 effector 5; CEP5;
Entrez GeneID148170;
WB Predicted band size22kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse
ImmunogenSynthesized peptide derived from N-terminal of human BORG3.
FormulationPurified antibody in PBS with 0.05% sodium azide.

+ +

参考文献

以下是关于BORG3抗体的文献示例(注:BORG3相关研究较少,以下内容为模拟虚构,供参考):

---

1. **文献名称**:*BORG3 Antibody Characterization in Cell Migration Assays*

**作者**:Li, X. et al.

**摘要**:本研究开发了一种高特异性BORG3单克隆抗体,验证了其在抑制Cdc42介导的细胞骨架重组中的作用。实验表明,BORG3抗体可通过阻断BORG3与Cdc42的相互作用,显著抑制癌细胞的侵袭迁移能力。

2. **文献名称**:*Role of BORG3 in Breast Cancer Metastasis: Insights from Antibody-Based Inhibition*

**作者**:Wang, Y. & Zhang, R.

**摘要**:通过使用BORG3多克隆抗体,研究者发现BORG3在乳腺癌转移中通过调控细胞外基质降解相关蛋白(如MMP-9)表达,促进肿瘤侵袭。抗体阻断实验证实其潜在治疗价值。

3. **文献名称**:*Development of a Novel BORG3-Specific Antibody for Immunohistochemical Applications*

**作者**:Kim, S. et al.

**摘要**:研究团队报道了一种新型BORG3抗体,优化了其在石蜡包埋组织中的免疫组化应用。该抗体在结肠癌样本中显示BORG3高表达与患者不良预后相关,提示其作为生物标志物的潜力。

---

**备注**:实际研究中,BORG3(Binder of Rho GTPases 3)可能与细胞迁移、癌症进展相关,但具体文献需通过学术数据库(如PubMed)检索确认。若需真实文献,建议结合更广泛的关键词(如“BORG3/Cdc42 antibody”或“BORG3 function”)进一步探索。

背景信息

The BORG3 (BMP/OPG Responsive Gene 3) antibody is designed to detect the BORG3 protein, a member of the Cysteine-Rich Protein (CRP) family. BORG3. also known as Cysteine-Rich Motor Neuron 2 (CRIM2), is encoded by the CRIM2 gene and shares structural homology with other BORG family members (BORG1-BORG5). These proteins contain conserved LIM domains, which mediate protein-protein interactions involved in cytoskeletal organization and cell adhesion. BORG3 is implicated in regulating cell migration, extracellular matrix (ECM) remodeling, and epithelial-mesenchymal transition (EMT), processes critical in development and cancer metastasis. Studies suggest its role in modulating Rho GTPase signaling pathways to influence actin cytoskeleton dynamics. In cancer research, BORG3 overexpression has been linked to aggressive phenotypes in breast, colorectal, and prostate cancers, correlating with metastasis and poor prognosis. The BORG3 antibody is widely used in immunohistochemistry, Western blotting, and immunofluorescence to assess protein expression patterns in tissues or cell lines, aiding investigations into its biological functions and potential as a therapeutic target. Its development supports ongoing exploration of BORG3's mechanistic contributions to cellular motility and tumor progression.

客户数据及评论

折叠内容

大包装询价

×